Literature DB >> 9895290

Basic fibroblast growth factor does not prevent heparan sulphate proteoglycan catabolism in intact cells, but it alters the distribution of the glycosaminoglycan degradation products.

S Tumova1, B A Hatch, D J Law, K J Bame.   

Abstract

Heparan sulphate proteoglycans on cell surfaces have been shown to mediate the degradation or recycling of several ligands. Since the interaction with ligand may affect proteoglycan catabolism once the complex is internalized, this could alter the cellular pool of heparan sulphate chains, with possible consequences for heparan sulphate-mediated cellular processes. We have recently demonstrated that the specific binding of basic fibroblast growth factor (bFGF) to heparan sulphate chains prevents the glycosaminoglycan from being degraded by partially purified heparanases from Chinese hamster ovary (CHO) cells [Tumova and Bame (1997) J. Biol. Chem. 272, 9078-9085]. The present study examines the effect of bFGF on heparan sulphate catabolism in intact cells. The distribution and size of the heparan sulphate degradation products in CHO cells was analysed in the presence and absence of bFGF using pulse-chase protocols. Although heparan sulphate molecules and bFGF are internalized through the same pathway, even relatively high concentrations of the growth factor do not have any inhibitory effects on glycosaminoglycan degradation. However, the interaction with the growth factor alters the distribution of heparan sulphate-degradation products, presumably by preventing secretion of the short heparanase-derived species. Our findings show that most of the free and bFGF-bound heparan sulphate chains are destined for lysosomes, which would be consistent with a recent hypothesis that the primary role of proteoglycan-mediated internalization of the growth factor is to remove bFGF from its site of action at the cell surface. However, in the presence of bFGF, a fraction of intracellular, heparanase-degraded heparan sulphate chains is delivered to the nucleus, suggesting that the glycosaminoglycan accompanies the growth factor to the organelle. It may be important for bFGF activity that the growth factor is protected from proteolytic degradation by its interaction with heparan sulphate. This work demonstrates that the internalization of a ligand along with the proteoglycan can affect the sorting of heparan sulphate-degradation products in endosomes, and the ultimate destination of the short glycosaminoglycan. It also provides evidence that formation of heparan sulphate-ligand complexes may regulate the recycling and degradation of both ligands and heparan sulphate chains and, consequently, affect their biological activities.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9895290      PMCID: PMC1219998     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  42 in total

Review 1.  The FGF family of growth factors and oncogenes.

Authors:  C Basilico; D Moscatelli
Journal:  Adv Cancer Res       Date:  1992       Impact factor: 6.242

Review 2.  The role of proteoglycans in cell adhesion, migration and proliferation.

Authors:  T N Wight; M G Kinsella; E E Qwarnström
Journal:  Curr Opin Cell Biol       Date:  1992-10       Impact factor: 8.382

3.  Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation.

Authors:  A C Rapraeger; A Krufka; B B Olwin
Journal:  Science       Date:  1991-06-21       Impact factor: 47.728

4.  Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor.

Authors:  A Yayon; M Klagsbrun; J D Esko; P Leder; D M Ornitz
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

Review 5.  Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism?

Authors:  I Vlodavsky; R Bar-Shavit; R Ishai-Michaeli; P Bashkin; Z Fuks
Journal:  Trends Biochem Sci       Date:  1991-07       Impact factor: 13.807

6.  Kinetics of basic fibroblast growth factor binding to its receptor and heparan sulfate proteoglycan: a mechanism for cooperactivity.

Authors:  M A Nugent; E R Edelman
Journal:  Biochemistry       Date:  1992-09-22       Impact factor: 3.162

7.  Basic fibroblast growth factor is internalized through both receptor-mediated and heparan sulfate-mediated mechanisms.

Authors:  M Roghani; D Moscatelli
Journal:  J Biol Chem       Date:  1992-11-05       Impact factor: 5.157

8.  Basic fibroblast growth factor (bFGF) dissociates rapidly from heparan sulfates but slowly from receptors. Implications for mechanisms of bFGF release from pericellular matrix.

Authors:  D Moscatelli
Journal:  J Biol Chem       Date:  1992-12-25       Impact factor: 5.157

9.  Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells.

Authors:  D M Ornitz; A Yayon; J G Flanagan; C M Svahn; E Levi; P Leder
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

10.  Developmental changes in heparan sulfate expression: in situ detection with mAbs.

Authors:  G David; X M Bai; B Van der Schueren; J J Cassiman; H Van den Berghe
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

View more
  10 in total

1.  Characterization of a novel intracellular heparanase that has a FERM domain.

Authors:  Karen J Bame; Indumati Venkatesan; Jean Dehdashti; Jeffrey McFarlane; Rebecca Burfeind
Journal:  Biochem J       Date:  2002-05-15       Impact factor: 3.857

Review 2.  Intracellular proteoglycans.

Authors:  Svein Olav Kolset; Kristian Prydz; Gunnar Pejler
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

3.  Biochemical characterization of the active heterodimer form of human heparanase (Hpa1) protein expressed in insect cells.

Authors:  Edward McKenzie; Kathryn Young; Margaret Hircock; James Bennett; Maina Bhaman; Robert Felix; Paul Turner; Alasdair Stamps; David McMillan; Giles Saville; Stanley Ng; Sean Mason; Daniel Snell; Darren Schofield; Haiping Gong; Reid Townsend; John Gallagher; Martin Page; Raj Parekh; Colin Stubberfield
Journal:  Biochem J       Date:  2003-07-15       Impact factor: 3.857

4.  Fibroblast growth factor 2 induced proliferation in osteoblasts and bone marrow stromal cells: a whole cell model.

Authors:  Melissa A Dupree; Solomon R Pollack; Elliot M Levine; Cato T Laurencin
Journal:  Biophys J       Date:  2006-07-21       Impact factor: 4.033

Review 5.  The heparanase/syndecan-1 axis in cancer: mechanisms and therapies.

Authors:  Vishnu C Ramani; Anurag Purushothaman; Mark D Stewart; Camilla A Thompson; Israel Vlodavsky; Jessie L-S Au; Ralph D Sanderson
Journal:  FEBS J       Date:  2013-03-04       Impact factor: 5.542

Review 6.  Heparan sulfate in the nucleus and its control of cellular functions.

Authors:  Mark D Stewart; Ralph D Sanderson
Journal:  Matrix Biol       Date:  2013-12-03       Impact factor: 11.583

7.  Efficient Construction of Atomic-Resolution Models of Non-Sulfated Chondroitin Glycosaminoglycan Using Molecular Dynamics Data.

Authors:  Elizabeth K Whitmore; Gabriel Vesenka; Hanna Sihler; Olgun Guvench
Journal:  Biomolecules       Date:  2020-04-02

8.  A gradient of matrix-bound FGF-2 and perlecan is available to lens epithelial cells.

Authors:  Weiju Wu; Frederique M Tholozan; Martin W Goldberg; Leon Bowen; Junjie Wu; Roy A Quinlan
Journal:  Exp Eye Res       Date:  2013-12-14       Impact factor: 3.467

9.  An investigation of genetic polymorphisms in heparan sulfate proteoglycan core proteins and key modification enzymes in an Australian Caucasian multiple sclerosis population.

Authors:  Rachel K Okolicsanyi; Julia Bluhm; Cassandra Miller; Lyn R Griffiths; Larisa M Haupt
Journal:  Hum Genomics       Date:  2020-05-12       Impact factor: 4.639

10.  Constructing 3-Dimensional Atomic-Resolution Models of Nonsulfated Glycosaminoglycans with Arbitrary Lengths Using Conformations from Molecular Dynamics.

Authors:  Elizabeth K Whitmore; Devon Martin; Olgun Guvench
Journal:  Int J Mol Sci       Date:  2020-10-18       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.